or Try an Advanced Search...

    Technical Analysis for SEEL - Seelos Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.66 -43.59% -0.51
    SEEL closed down 8.59 percent on Wednesday, October 16, 2024, on 45 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SEEL trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish -43.59%
    Lizard Bullish Bullish Day Trade Setup -43.59%
    Doji - Bullish? Reversal -43.59%
    Lower Bollinger Band Walk Weakness -43.59%
    New 52 Week Low Weakness -43.59%
    Wide Bands Range Expansion -43.59%
    Below Lower BB Weakness -43.59%
    Lower Bollinger Band Touch Weakness -43.59%
    Oversold Stochastic Weakness -43.59%
    New 52 Week Closing Low Bearish -48.44%
    Older End-of-Day Signals for SEEL ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 5 hours ago
    Gapped Down (Full) about 10 hours ago
    Down 5% about 10 hours ago
    Down 3% about 10 hours ago
    Fell Below Lower Bollinger Band about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SEEL Chart by TradingView
    Basic chart:

    Profile

    Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Disorders Movement Disorders Orphan Disease

    Is SEEL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 24 Seelos Announces Second Postponement of its Annual Meeting of Stockholders
    Oct 15 Seelos gets Nasdaq delisting notice
    Oct 15 Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market
    Sep 27 Crude Oil Rises; Onconetix Shares Spike Higher
    Sep 27 Top Midday Decliners
    Sep 27 Dow Surges Over 100 Points; Costco Earnings Top Views
    Sep 26 Seelos Announces Postponement of its Annual Meeting of Stockholders
    Sep 25 Seelos Therapeutics to execute 1-for-16 reverse stock split
    Sep 25 Seelos Therapeutics Announces 1-for-16 Reverse Stock Split
    Sep 25 Seelos Therapeutics files to sell common stock, warrants, no amount given
    See more SEEL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 848.64
    52 Week Low 0.82
    Average Volume 710,445
    200-Day Moving Average 52.85
    50-Day Moving Average 3.84
    20-Day Moving Average 3.22
    10-Day Moving Average 2.56
    Average True Range 0.73
    RSI (14) 10.71
    ADX 38.95
    +DI 9.27
    -DI 45.78
    Chandelier Exit (Long, 3 ATRs) 6.66
    Chandelier Exit (Short, 3 ATRs) 3.02
    Upper Bollinger Bands 5.28
    Lower Bollinger Band 1.17
    Percent B (%b) 0.0
    BandWidth 127.55
    MACD Line -0.66
    MACD Signal Line -0.49
    MACD Histogram -0.1771
    Fundamentals Value
    Market Cap 16.01 Million
    Num Shares 13.7 Million
    EPS -12.90
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 7.03
    Price-to-Book 15.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.86
    Resistance 3 (R3) 1.82 1.55 1.75
    Resistance 2 (R2) 1.55 1.37 1.57 1.71
    Resistance 1 (R1) 1.36 1.27 1.23 1.40 1.67
    Pivot Point 1.09 1.09 1.02 1.11 1.09
    Support 1 (S1) 0.90 0.91 0.77 0.94 0.67
    Support 2 (S2) 0.63 0.81 0.65 0.63
    Support 3 (S3) 0.44 0.63 0.60
    Support 4 (S4) 0.48